Punch & Associates Investment Management’s Streamline Health Solutions STRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,100
Closed -$103K 238
2023
Q3
$103K Sell
7,100
-89,247
-93% -$1.55M 0.01% 209
2023
Q2
$1.84M Hold
96,347
0.11% 151
2023
Q1
$2.6M Sell
96,347
-753
-0.8% -$21.4K 0.17% 140
2022
Q4
$2.3M Hold
97,100
0.15% 151
2022
Q3
$1.73M Sell
97,100
-11,367
-10% -$255K 0.12% 156
2022
Q2
$2.07M Sell
108,467
-4,806
-4% -$96.6K 0.14% 154
2022
Q1
$2.72M Sell
113,273
-194
-0.2% -$4.16K 0.15% 152
2021
Q4
$2.54M Hold
113,467
0.13% 157
2021
Q3
$2.98M Buy
113,467
+7,100
+7% +$175K 0.17% 156
2021
Q2
$2.82M Buy
106,367
+13,700
+15% +$408K 0.16% 162
2021
Q1
$2.85M Buy
+92,667
New +$2.66M 0.17% 153

Other funds holding STRM

Punch & Associates Investment Management's STRM Position: Q4 2023 in Review

Punch & Associates Investment Management sold out of Streamline Health Solutions (STRM) in Q4 2023, closing a stake of 7,100 shares — an estimated $103K sold.

Punch & Associates Investment Management first reported a position in STRM in Q1 2021 and held it in 11 quarters. The position peaked at $2.98M in Q3 2021. 40 funds tracked by Wall St. Rank hold STRM as of Q4 2023.

  • Punch & Associates Investment Management reported no remaining Streamline Health Solutions position as of Q4 2023 after selling out during the quarter.
  • Punch & Associates Investment Management sold 7,100 Streamline Health Solutions shares in Q4 2023, an estimated $103K.
  • Punch & Associates Investment Management first reported a position in Streamline Health Solutions in Q1 2021 and held it in 11 quarters.
  • Punch & Associates Investment Management's Streamline Health Solutions position peaked at $2.98M in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Streamline Health Solutions as of Q4 2023.

Based on Punch & Associates Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.